Norah Al-Azzam, co-founder of NanoMood and serving as its CTO, earned her PhD with a focus on unraveling the mysteries of the brain. With a deep-seated passion for Neurodegeneration and RNA therapeutics, she brings extensive expertise to her role. During her tenure as a Researcher at UC San Diego, she immersed herself in cutting-edge research, specializing in assay development, proteomics, and drug development. Furthermore, her time as an Associate Scientist at Abbott provided her with valuable skills in enhancing point-of-care management capabilities for infectious diseases, including the development of rapid detection assays for COVID-19 and other pathogens. Norah is also the co-founder of NanoMood, a digital health innovation startup that pioneers a platform integrating biometric data for neurological treatment management. Their vision aims to revolutionize neurological care by providing comprehensive insights and personalized solutions through the utilization of biometric data.